Bellevue Group’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $229M | Hold |
1,820,000
| – | – | 5.04% | 3 |
|
|
2025
Q1 | $201M | Hold |
1,820,000
| – | – | 4.51% | 7 |
|
|
2024
Q4 | $248M | Sell |
1,820,000
-43,800
| -2% | -$5.98M | 4.78% | 3 |
|
|
2024
Q3 | $215M | Sell |
1,863,800
-34,840
| -2% | -$4.01M | 3.48% | 7 |
|
|
2024
Q2 | $261M | Sell |
1,898,640
-157,234
| -8% | -$21.6M | 4.25% | 4 |
|
|
2024
Q1 | $284M | Sell |
2,055,874
-374,626
| -15% | -$51.7M | 4.32% | 3 |
|
|
2023
Q4 | $320M | Sell |
2,430,500
-153,050
| -6% | -$20.2M | 4.9% | 3 |
|
|
2023
Q3 | $291M | Sell |
2,583,550
-29,250
| -1% | -$3.29M | 4.68% | 4 |
|
|
2023
Q2 | $246M | Sell |
2,612,800
-500
| -0% | -$47.2K | 3.51% | 5 |
|
|
2023
Q1 | $265M | Sell |
2,613,300
-159,994
| -6% | -$16.2M | 3.84% | 4 |
|
|
2022
Q4 | $331M | Sell |
2,773,294
-81,852
| -3% | -$9.78M | 4.4% | 3 |
|
|
2022
Q3 | $303M | Buy |
2,855,146
+10,841
| +0.4% | +$1.15M | 4.35% | 4 |
|
|
2022
Q2 | $277M | Sell |
2,844,305
-179,146
| -6% | -$17.5M | 3.92% | 4 |
|
|
2022
Q1 | $283M | Sell |
3,023,451
-157,100
| -5% | -$14.7M | 3.29% | 4 |
|
|
2021
Q4 | $271M | Buy |
3,180,551
+176,500
| +6% | +$15M | 2.79% | 5 |
|
|
2021
Q3 | $288M | Sell |
3,004,051
-13,700
| -0.5% | -$1.31M | 2.92% | 5 |
|
|
2021
Q2 | $294M | Sell |
3,017,751
-256,800
| -8% | -$25M | 2.87% | 4 |
|
|
2021
Q1 | $318M | Sell |
3,274,551
-122,100
| -4% | -$11.9M | 3.37% | 3 |
|
|
2020
Q4 | $326M | Buy |
3,396,651
+99,200
| +3% | +$9.51M | 3.73% | 2 |
|
|
2020
Q3 | $317M | Buy |
3,297,451
+86,551
| +3% | +$8.32M | 4.38% | 2 |
|
|
2020
Q2 | $392M | Sell |
3,210,900
-48,574
| -1% | -$5.93M | 5.54% | 2 |
|
|
2020
Q1 | $282M | Sell |
3,259,474
-58,900
| -2% | -$5.1M | 5.47% | 3 |
|
|
2019
Q4 | $357M | Buy |
3,318,374
+19,900
| +0.6% | +$2.14M | 5.66% | 2 |
|
|
2019
Q3 | $297M | Sell |
3,298,474
-247,970
| -7% | -$22.3M | 5.53% | 2 |
|
|
2019
Q2 | $299M | Buy |
3,546,444
+3,526,244
| +17,457% | +$298M | 5.11% | 3 |
|
|
2019
Q1 | $1.78M | Sell |
20,200
-19,850
| -50% | -$1.75M | 0.1% | 112 |
|
|
2018
Q4 | $2.86M | Sell |
40,050
-1,500
| -4% | -$107K | 0.19% | 91 |
|
|
2018
Q3 | $5.11M | Sell |
41,550
-2,000
| -5% | -$246K | 0.32% | 71 |
|
|
2018
Q2 | $4.28M | Sell |
43,550
-10,100
| -19% | -$992K | 0.36% | 59 |
|
|
2018
Q1 | $4.45M | Sell |
53,650
-850
| -2% | -$70.5K | 0.44% | 55 |
|
|
2017
Q4 | $4.23M | Sell |
54,500
-1,500
| -3% | -$116K | 0.44% | 52 |
|
|
2017
Q3 | $3.43M | Buy |
56,000
+9,000
| +19% | +$552K | 0.36% | 63 |
|
|
2017
Q2 | $2.16M | Sell |
47,000
-21,000
| -31% | -$966K | 0.26% | 79 |
|
|
2017
Q1 | $2.94M | Sell |
68,000
-7,000
| -9% | -$303K | 0.39% | 65 |
|
|
2016
Q4 | $2.9M | Buy |
75,000
+17,000
| +29% | +$658K | 0.59% | 48 |
|
|
2016
Q3 | $2.94M | Hold |
58,000
| – | – | 0.53% | 55 |
|
|
2016
Q2 | $2.64M | Sell |
58,000
-7,000
| -11% | -$318K | 0.5% | 65 |
|
|
2016
Q1 | $2.57M | Buy |
+65,000
| New | +$2.57M | 0.47% | 69 |
|